base-metals-investing First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
base-metals-investing Real-World Evidence Studies of XPHOZAH® Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
base-metals-investing Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
base-metals-investing Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
base-metals-investing Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® at the American College of Gastroenterology's 2025 Annual Meeting
base-metals-investing Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week
base-metals-investing Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
